Heparin Protocol Awareness and Scope Boundaries
Key Takeaways
- Heparin is used to reduce clotting in the extracorporeal circuit during dialysis, not to fix an access problem.
- The technician follows the ordered heparin protocol only within facility policy, state rules, and assigned training.
- Bleeding, recent surgery, allergy history, unusual bruising, or conflicting orders must be reported before heparin steps proceed.
- Circuit clotting signs and prolonged post-needle bleeding both require reporting and documentation according to policy.
Heparin Protocol Awareness
During dialysis, blood contacts tubing, chambers, and the dialyzer. Heparin may be ordered to reduce clotting in the extracorporeal circuit. It does not correct a stenosed access, replace good blood flow, or make unsafe cannulation acceptable.
A heparin protocol may include a bolus, maintenance infusion, stop time before the end of treatment, or a heparin-free approach. The technician must follow the prescription and facility policy exactly. If the order is missing, unclear, or different from the machine setting, the safe action is to clarify before proceeding.
| Concern | CCHT response |
|---|---|
| Active bleeding, recent procedure, severe bruising, or reported heparin allergy | Report before heparin administration steps |
| Dark streaks in dialyzer or clots in venous chamber | Report possible circuit clotting per protocol |
| Prolonged bleeding after needle removal on prior treatments | Communicate and document according to policy |
| Heparin-free order | Do not give routine heparin; follow ordered alternatives |
Scope is central. In some settings a trained technician may perform heparin-related tasks; in others, the nurse or another qualified clinician must do them. The CCHT exam expects protocol awareness, not independent medication decisions.
When clotting or bleeding occurs, do not independently change dose, timing, or pump rate. Report the finding, protect the patient and circuit, and document the event in the treatment record according to facility procedure.
A patient scheduled for routine heparin reports active nosebleeding before treatment. What should the technician do?
During treatment, the dialyzer shows dark streaking and the venous chamber has visible clots. What is the best interpretation?
The heparin pump setting does not match the prescribed protocol at treatment initiation. What is the safest response?